Cutaneous T-cell lymphoma - Lymphoma Association

Macmillan Cancer SupportProvides practical, medical, emotional and financial help, as well as comprehensiveinformation on all aspects of cancers, treatments and living with cancer. 0808 808 0000 via websitewww.macmillan.org.ukSkinship (UK)A confidential dermatology helpline that supports anyone affected by a skin conditionand lobbies for improved dermatology training in the UK. Run by Ashley Medicks, whohas had mycosis fungoides for over 40 years. 01387 760 567 amedicks321@btinternet.comwww.careinfoscotland.co.uk/system/full-record.aspx?id=414ReferencesPerry MC (editor). The Chemotherapy Source Book. 4th edition. 2008. Lippincott,Williams & Wilkins. Philadelphia, USA.Swerdlow SH, et al. World Health Organization classification of tumours: pathologyand genetics of tumours of haematopoietic and lymphoid tissues. 2008. IARC Press,Lyon, France.Marcus R, et al (eds). Lymphoma: pathology, diagnosis and treatment. 2007.Cambridge University Press, Cambridge, UK.Willemze R, Dreyling M, and the ESMO Guidelines Working Group. Primary cutaneouslymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup.Annals of Oncology, 2010. 21(Suppl 5): v177–v180. Available at: http://annonc.oxfordjournals.org/content/21/suppl_5/v177.full (accessed 5 April 2013).Prince HM, et al. How I treat mycosis fungoides and Sézary syndrome. Blood, 2009.114: 4337–4353.Scarisbrick J. Extracorporeal photopheresis: what is it and when should it be used?Clinical and Experimental Dermatology, 2009. 34:757–760.Kim YH, et al., ISCL/EORTC. TNM classification system for primary cutaneouslymphomas other than mycosis fungoides and Sézary syndrome: a proposal of theIntenational Sociaty for Cutaneous Lymphomas (ISCL) and the Cutaneous LymphomaStudy Group of the European Organization of Research and Treatment of Cancer(EORTC). Blood, 2007. 110: 479–484.Olsen E, et al., ISCL/EORTC. Revisions to the staging and classification of mycosisfungoides and Sezary syndrome: a proposal of the International Society for CutaneousLymphomas (ISCL) and the cutaneous lymphoma task force of the EuropeanOrganization of Research and Treatment of Cancer (EORTC). Blood, 2007. 110: 1713–1722.Trautinger F, et al. EORTC consensus recommendations for the treatment of mycosistungoides/Sézary syndrome. European Journal of Cancer, 2006. 42: 1014–1030.Cutaneous T-cell lymphomaLYM0157/CTCL/2013v317/18